ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,596,341 | -12.6% | 1,276,216 | +0.4% | 0.29% | -11.7% |
| Q2 2023 | $30,447,252 | +18.4% | 1,271,284 | -7.0% | 0.33% | -6.2% |
| Q1 2023 | $25,710,899 | +48.4% | 1,367,601 | +25.5% | 0.36% | +40.3% |
| Q4 2022 | $17,330,555 | +1270.0% | 1,089,972 | +1310.2% | 0.25% | +1165.0% |
| Q3 2022 | $1,265,000 | +37.9% | 77,292 | +18.9% | 0.02% | +53.8% |
| Q2 2022 | $917,000 | -80.9% | 65,019 | -44.1% | 0.01% | -74.5% |
| Q3 2020 | $4,796,000 | – | 116,258 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |